Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Intraductal, Noninfiltrating

Explore clinical trials studying Carcinoma, Intraductal, Noninfiltrating. Study availability and eligibility vary by location and protocol.

218 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Intraductal, Noninfiltrating trial results

Completed

Letrozole in Preventing Breast Cancer in Postmenopausal Women

NCT00090857

Conditions
Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ

NCT01439711

Conditions
Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Bay Area Tumor Institute Oakland, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
  • Exempla Saint Joseph Hospital Denver, Colorado, United States
View all 32 locations
View Trial Details
Completed

S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer

NCT01097278

Conditions
Adenocarcinoma, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +14 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Regional Hospital Anchorage, Alaska, United States
View all 360 locations
View Trial Details
Completed

Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen

NCT00764322

Conditions
Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +13 more
Locations
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
  • Blumenthal Cancer Center at Carolinas Medical Center Charlotte, North Carolina, United States
  • Duke Comprehensive Cancer Center Durham, North Carolina, United States
  • Moses Cone Regional Cancer Center at Wesley Long Community Hospital Greensboro, North Carolina, United States
View Trial Details

Related conditions